^99mTc-depreotide scintigraphy of bone lesions in patients with lung cancer

By Mena Esther   Camacho Valle   Estorch Montserrat   Fuertes Jordi   Flotats Albert   Carrió Ignasi  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 10, 2004-10 ,pp. : 1399-1404

Springer Publishing Company

Access to resources Recommend Favorite

Oestrogen-mediated regulation of somatostatin receptor expression in human breast cancer cell lines assessed with ^99mTc-depreotide

By Bossche B.   D’haeninck E.   Vos F.   Dierckx R.   Belle S.   Bracke M.   Wiele C.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 7, 2004-07 ,pp. : 1022-1030

Springer Publishing Company

Access to resources Recommend Favorite

Somatostatin Receptor Scintigraphy with 99m Tc-Depreotide (NeoSpect) in Discriminating between Malignant and Benign Lesions in the Diagnosis of Lung Cancer: a Pilot Study

By Bååth M.   Kölbeck K. G.   Danielsson R.  

Acta Radiologica, Vol. 45, Iss. 8, 2004-12 ,pp. : 833-839

Blackwell Publishing

Access to resources Recommend Favorite

Diagnosis and staging of children’s lymphoma using the technetium-labelled somatostatin analogue, ^99mTc-depreotide

By Cholewinski Witold   Kowalczyk Jerzy   Stefaniak Bogusław   Stefaniak Jolanta   Poniatowicz-Frasunek Ewa   Tarkowska Anna  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 6, 2004-06 ,pp. : 820-824

Springer Publishing Company

Access to resources Recommend Favorite

Volume-based assessment by ¹⁸F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer

By Hyun Seung   Ahn Hee   Kim Hojoong   Ahn Myung-Ju   Park Keunchil   Ahn Yong   Kim Jhingook   Shim Young   Choi Joon  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 41, Iss. 1, 2014-01 ,pp. : 50-58

Springer Publishing Company

Access to resources Recommend Favorite